Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using a bispecific antigen-binding construct targeting HER2 for the treatment of biliary tract cancers

Methods of using a bispecific antigen-binding construct targeting HER2 for the treatment of biliary tract cancers

US Patent 12435157 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Anti-HER2 biparatopic antibody-drug conjugates and methods of use2025
Methods of using a bispecific antigen-binding construct targeting HER2 in combin2024
Methods of using a bispecific antigen-binding construct targeting HER2 in combin2024
Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy2023
Pharmaceutical composition comprising PDE9 inhibitor2022
Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer2022
Methods of reducing immunogenicity against factor VIII in individuals undergoing2022
Anti-HER2 biparatopic antibody-drug conjugates and methods of use2021
Methods of reducing immunogenicity against factor VIII in individuals undergoing2019
MUC1 based glycolipopeptide vaccine with adjuvant2014
Suppression of immune response to factor VIII in hemophilia A patients2014